Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

10mg dextroamphetamine?

See the DrugPatentWatch profile for dextroamphetamine

The query is for "10mg dextroamphetamine". This is a specific dosage of a medication. To provide a comprehensive answer that addresses potential user search intent, the response should cover what dextroamphetamine is, what it's used for, dosage information, and related considerations like patents and availability.

What is Dextroamphetamine?


Dextroamphetamine is a central nervous system stimulant that is primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy [1]. It works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain, which can improve focus, attention, and impulse control [1]. It is available in various dosage forms, including immediate-release and extended-release formulations [2].

What is 10mg Dextroamphetamine Used For?


A 10mg dosage of dextroamphetamine is a common prescription strength for treating the symptoms of ADHD in both children and adults. For narcolepsy, it can also be prescribed to help patients stay awake during the day [1]. The specific dosage and frequency are determined by a healthcare professional based on the individual's condition, response to treatment, and other health factors [3].

How is Dextroamphetamine Typically Dosed?


Dosage for dextroamphetamine is highly individualized. For ADHD, treatment typically begins with a lower dose and is gradually increased as needed and tolerated. A starting dose might be 5mg to 10mg per day, taken once or twice daily, with subsequent adjustments made by the prescribing physician [3]. A 10mg dose can be a maintenance dose for some individuals or an intermediate step in titration for others. Extended-release formulations may have different dosing schedules.

When Does Dextroamphetamine Patent Exclusivity Expire?


Information regarding specific drug patents and their expiration dates can be found on specialized databases. DrugPatentWatch.com is a resource that tracks these details [4]. For dextroamphetamine, as it is an older medication with a long history, many of the original patents have expired, leading to the availability of generic versions. However, specific formulations or delivery methods might have had more recent patent protections.

Who Manufactures Dextroamphetamine?


Multiple pharmaceutical companies manufacture dextroamphetamine, particularly generic versions, due to patent expirations on the original formulations. Major generic manufacturers and some brand-name producers offer dextroamphetamine products. For example, common brand names have included Dexedrine and Vyvanse (lisdexamfetamine dimesylate, which metabolizes to dextroamphetamine), alongside numerous generic options [2].

What are the Risks and Side Effects of Dextroamphetamine?


Like all medications, dextroamphetamine carries potential risks and side effects. Common side effects can include decreased appetite, dry mouth, insomnia, weight loss, irritability, and increased heart rate or blood pressure [1]. More serious side effects, though less common, can include cardiovascular problems, psychiatric issues such as hallucinations or mania, and growth suppression in children [1]. Dextroamphetamine also carries a risk of abuse and dependence [3].

Can Generic Dextroamphetamine Be Prescribed?


Yes, generic dextroamphetamine is widely available and prescribed. Once the patents for the original brand-name drug expire, other manufacturers can produce and market generic equivalents. These generic versions contain the same active ingredient, dextroamphetamine, and are required to meet the same standards for safety, quality, and efficacy as the brand-name drug [2]. They are typically prescribed as an alternative to the brand-name medication.

How Does Dextroamphetamine Compare to Other ADHD Medications?


Dextroamphetamine belongs to a class of medications known as stimulant medications, which are considered a first-line treatment for ADHD. Other stimulant medications include methylphenidate (found in Ritalin and Concerta) and amphetamine salts (found in Adderall). Non-stimulant medications are also available for ADHD, such as atomoxetine, guanfacine, and clonidine, and may be used if stimulants are not effective or tolerated [4]. Dextroamphetamine's specific mechanism and pharmacokinetic profile differentiate it from other stimulants and non-stimulants.

What is the Pricing of Dextroamphetamine?


The price of dextroamphetamine varies depending on whether it is a brand-name or generic product, the dosage, the quantity prescribed, and the pharmacy. Generic dextroamphetamine is generally significantly less expensive than brand-name versions [2]. Insurance coverage and patient assistance programs can also impact out-of-pocket costs.

Sources:
[1] National Institute of Mental Health. (n.d.). Attention-Deficit/Hyperactivity Disorder.
[2] U.S. Food & Drug Administration. (n.d.). Drugs@FDA.
[3] Mayo Clinic. (n.d.). Dextroamphetamine.
[4] DrugPatentWatch.com. (n.d.). Dextroamphetamine Patents.



Other Questions About Dextroamphetamine :

winder laboratories dextroamphetamine Dextroamphetamine name brand? What is the brand name for dextroamphetamine? Dextroamphetamine sulfate brand name? Does medicare cover dextroamphetamine er? Dextroamphetamine er info? Dextroamphetamine buy?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The only evaluated safety-related claim (“risk of abuse and dependence”) is supported by the provided FDA label excerpts describing high abuse/misuse potential leading to substance use disorder (including addiction), diversion, and increased overdose/death risk with higher doses or unapproved administration methods.


Category Scores

Warnings
100
Excellent

Accurate Statements

Dextroamphetamine carries a risk of abuse and dependence.
Supported by Section 5.1 and 9.2: high potential for abuse and misuse leading to substance use disorder including addiction; also discusses dependence (physical dependence) in Section 9.3.

Unsupported Statements


Contradictions


Important Omissions

The label text included in the prompt specifically emphasizes: (1) high potential for abuse/misuse leading to substance use disorder including addiction, (2) diversion for non-medical use, (3) increased overdose/death risk with higher doses or unapproved methods of administration (e.g., snorting or injection), and (4) patient counseling elements (assessment, education, disposal, locked storage, not sharing, reassessment and monitoring). None of these specific label counseling/risk details were mentioned in the AI claims.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The included abuse/dependence risk statement aligns with the provided FDA labeling. However, it lacks several specific label details (diversion, overdose/death risk conditions, and counseling/monitoring instructions) that could affect completeness of safety communication.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Safety completeness: omission of specific label details about abuse/misuse outcomes (addiction/substance use disorder), diversion, increased overdose/death risk with higher doses/unapproved administration routes, and patient counseling/monitoring steps.

Suggested Improvement
When discussing abuse/misuse, explicitly reflect the label’s phrasing: high potential for abuse/misuse leading to substance use disorder including addiction, potential diversion, and increased overdose/death risk with higher doses or unapproved routes (e.g., snorting/injection), along with counseling to store locked, not share, disposal of unused medication, and ongoing risk reassessment/monitoring.

Drug Brand Mention Assessment

Branding Score
45
Visibility
25
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

a central nervous system stimulant


Core Claims
  • Dextroamphetamine is a central nervous system stimulant
  • Used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy
  • Works by increasing neurotransmitters such as dopamine and norepinephrine
  • Common side effects include decreased appetite, dry mouth, insomnia, and weight loss
  • Carries a risk of abuse and dependence
Differentiators
  • Mentioned as a first-line stimulant medication for ADHD
  • Specific mechanism and pharmacokinetic profile differentiate it from other stimulants and non-stimulants

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Mayo Clinic 20%
50 # No
National Institute of Mental Health 20%
50 # No
U.S. Food & Drug Administration 20%
50 # No
DrugPatentWatch 20%
50 # No